SAMIL PHARMACEUTICAL (000520)

Samil Pharmaceutical recorded one insider purchase during the past ninety days. Yong Hwan Sam acquired shares valued at 15,857,140 KRW on October 12, 2026. This activity coincides with a 32.1% stock price increase over the same period, occurring amidst a lack of recent earnings report data.
Ticker: 000520 Exchange: KOREA


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Yong Hwan Sam (용 환 삼) Unclassified position (전무) Officer
Transaction date
Purchase
Price
263.48
Quantity 86,626
Value ₩2,779,355
Heo Seung Beom (허 승 범) President (사장) Officer Large shareholder
Transaction date
Purchase
Price
294.91
Quantity 18,480 -3.3%
Value ₩398,734
Heo Seung Beom (허 승 범) President (사장) Officer Large shareholder
Transaction date
Purchase
Price
50.55
Quantity 25,655 +12.3%
Value ₩1,170,445
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-19 2026-10-12 B Purchase Yong Hwan Sam (용 환 삼)

Unclassified position (전무)

Officer
86,626
263.48
₩2,779,355
86,626 263.48 ₩2,779,355
2017-08-09 2017-08-09 B Purchase Heo Seung Beom (허 승 범)

President (사장)

Officer Large shareholder
18,480 -3.3%
294.91
₩398,734
18,480 -3.3% 294.91 ₩398,734
2017-04-26 2017-04-26 B Purchase Heo Seung Beom (허 승 범)

President (사장)

Officer Large shareholder
25,655 +12.3%
50.55
₩1,170,445
25,655 +12.3% 50.55 ₩1,170,445
Explore more

More insider trading research around SAMIL PHARMACEUTICAL